Semi-Annual Consolidated Statement Of Cash Flows

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7298417

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
4,558,000,000 JPY
-2,511,000,000 JPY
Interest and dividends received
699,000,000 JPY
674,000,000 JPY
Interest paid
-10,000,000 JPY
-9,000,000 JPY
Income taxes paid
-2,472,000,000 JPY
-486,000,000 JPY
Net cash provided by (used in) operating activities
2,775,000,000 JPY
-2,333,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,993,000,000 JPY
-553,000,000 JPY
Proceeds from sale of property, plant and equipment
13,000,000 JPY
58,000,000 JPY
Purchase of investment securities
-508,000,000 JPY
-1,950,000,000 JPY
Loan advances
JPY
-3,000,000 JPY
Proceeds from collection of loans receivable
1,000,000 JPY
3,000,000 JPY
Other, net
-184,000,000 JPY
-32,000,000 JPY
Net cash provided by (used in) investing activities
2,779,000,000 JPY
3,653,000,000 JPY
Cash flows from financing activities
Proceeds from short-term borrowings
150,000,000 JPY
JPY
Repayments of short-term borrowings
-230,000,000 JPY
-100,000,000 JPY
Purchase of treasury shares
0 JPY
-949,000,000 JPY
Dividends paid
-1,812,000,000 JPY
-1,844,000,000 JPY
Net cash provided by (used in) financing activities
-1,960,000,000 JPY
-2,959,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-40,000,000 JPY
5,000,000 JPY
Net increase (decrease) in cash and cash equivalents
3,553,000,000 JPY
-1,632,000,000 JPY
Cash and cash equivalents
49,440,000,000 JPY
45,887,000,000 JPY
47,251,000,000 JPY
48,884,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.